Opendata, web and dolomites

MeDiTATe SIGNED

The Medical Digital Twin for Aneurysm Prevention and Treatment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MeDiTATe project word cloud

Explore the words cloud of the MeDiTATe project. It provides you a very rough idea of what is the project "MeDiTATe" about.

patient    innovative    clinical    secondments    twin    skills    faced    expertise    receiving    18    life    additive    clinic    digital    augmented    rbf    introduce    physical    hpc    meditate    districts    sectors    months    planning    cae    players    fem    manufacturing    time    daily    individual    simulation    paradigms    interaction    big    edge    enrolled    image    innovation    morphing    postgraduate    inverse    gain    imaging    tools    prevention    fsi    esrs    fidelity    14    patients    competitive    disciplinary    mock    experts    cardiovascular    scenario    flexible    integration    medical    aneurysms    automated    cloud    data    technological    academic    recruited    surgical    gpus    treatment    tracks    cfd    developers    scientific    haptic    scientists    models    physics    healthcare    periods    designed    scenarios    cutting    hired    twins    industry    sectoral    phd    trained    industrial    training    software    database    active    engineering    strategic    population    mesh    fast    medicine    career    skill   

Project "MeDiTATe" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA 

Organization address
address: VIA CRACOVIA 50
city: ROMA
postcode: 133
website: www.uniroma2.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 3˙750˙403 €
 EC max contribution 3˙750˙403 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-EID
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA IT (ROMA) coordinator 522˙999.00
2    FONDAZIONE TOSCANA GABRIELE MONASTERIO PER LA RICERCA MEDICA E DI SANITA PUBBLICA IT (PISA) participant 392˙249.00
3    NATIONAL TECHNICAL UNIVERSITY OF ATHENS - NTUA EL (ATHINA) participant 364˙526.00
4    SINTEF AS NO (TRONDHEIM) participant 292˙342.00
5    TECHNEVALUE GMBH CH (BACH) participant 281˙276.00
6    ANSYS FRANCE SAS FR (MONTIGNY LE BRETONNEUX) participant 274˙802.00
7    ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS FR (PARIS) participant 274˙802.00
8    ESI GROUP FR (PARIS) participant 274˙802.00
9    PHILIPS FRANCE COMMERCIAL FR (SURESNES) participant 274˙802.00
10    PREDISURGE FR (SAINT-ETIENNE) participant 274˙802.00
11    HSL SRL IT (TRENTO) participant 261˙499.00
12    RINA CONSULTING SPA IT (GENOVA) participant 261˙499.00

Map

 Project objective

MeDiTATe aims to develop state-of-the-art image based medical Digital Twins of cardiovascular districts for a patient specific prevention and treatment of aneurysms. The Individual Research Projects of the 14 ESRs are defined across five research tracks: (1) High fidelity CAE multi-physics simulation with RBF mesh morphing (FEM, CFD, FSI, inverse FEM) (2) Real time interaction with the digital twin by Augmented Reality, Haptic Devices and Reduced Order Models (3) HPC tools, including GPUs, and cloud-based paradigms for fast and automated CAE processing of clinical database (4) Big Data management for population of patients imaging data and high fidelity CAE twins (5) Additive Manufacturing of physical mock-up for surgical planning and training to gain a comprehensive Industry 4.0 approach in a clinical scenario (Medicine 4.0) The work of ESRs, each one hired for two 18 months periods (industry research) and enrolled in PhD programmes, will be driven by the multi disciplinary and multi-sectoral needs of the research consortium (clinical, academic and industrial) which will offer the expertise of Participants to provide scientific support, secondments and training. Recruited researchers will become active players of a strategic sector of the European medical and simulation industry and will face the industrial and research challenges daily faced by clinical experts, engineering analysts and simulation software technology developers. During their postgraduate studies they will be trained by the whole consortium receiving a flexible and competitive skill-set designed to address a career at the cutting edge of technological innovation in healthcare. The main objective of MeDiTATe is the production of high-level scientists with a strong experience of integration across academic, industrial and clinical areas, able to apply their skills to real life scenarios and capable to introduce advanced and innovative digital twin concepts in the clinic and healthcare sectors.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDITATE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDITATE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More